Status:
RECRUITING
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
NMO Spectrum Disorder
MRI
Eligibility:
All Genders
16-75 years
Brief Summary
CLUE is a prospective study to determine structural and functional changes of brain and spinal cord, as well as the inflammatory environment in patients with neuroinflammatory and demyelination diseas...
Detailed Description
The study is an observational study of multi-model imaging to determine structural and functional changes of the brain, spinal cord and optic nervethe and inflammatory environment in patients with neu...
Eligibility Criteria
Inclusion
- 16-75
- Diagnosis of neuroinflammatory and demyelination disease
- Availability of demographic and clinical data at the time disease onset
- Informed written consent obtained from the patient, and/or patient's parent(s), and/or legal representative. Assent, if old enough to grant, will be obtained from all patients under the age of 16 years.
Exclusion
- Patients for whom MRI is contra-indicated
- Patients included in an ongoing clinical trial where the product is blinded
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04106830
Start Date
January 1 2019
End Date
December 31 2028
Last Update
December 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100053